BRUSSELS – Device usability is a key component of the evaluation process and should neither be forgotten nor left to the last minute, experts told attendees at the 2023 RAPS European Clinical and Risk ...
PHILADELPHIA, Feb. 5, 2021 /PRNewswire/ -- In response to the evolving COVID-19 pandemic, Integral Molecular has adapted its SARS-CoV-2 reporter virus particle (RVP) technology to reflect emerging ...
PHILADELPHIA, Nov. 19, 2020 /PRNewswire/ -- JOINN Laboratories, China's leading preclinical contract research organization (CRO), has partnered with Integral Molecular to provide researchers in China ...